Ramadan
FULL PAPER
3157.25, 1604.66, 1255.57 cm - 1. Anal. calcd for
C7H15N3S: C 48.52, H 8.73, N 24.25; found C 48.24, H
8.61, N 24.09.
N'-[4-(4-Bromophenyl)thiazol-2-yl]-N-(2-chloro-
benzylidene)hydrazine (5d)
3.30 g (84%), m.p.
1
198—200 ℃; H NMR (DMSO-d6) δ: 7.36, 7.38 (2dd,
J=8.4, 8.4, 7.65, 7.65 Hz, 2H, Ar-H), 7.40 (s, 1H, thi-
azole-H), 7.47 (dd, J=6.85, 1.5 Hz, 1H), 7.57 (d, J=
8.4 Hz, 2H, Ar-H), 7.77 (d, J=8.4 Hz, 2H, Ar-H), 7.89
(dd, J=7.65, 2.3 Hz, 1H, Ar-H), 8.36 (s, 1H, =CH),
12.51 (s, 1H, D2O-exchangeable, NH); IR (KBr) ν:
4-Cyclopentylidene thiosemicarbazide (7b) 2.55
g (81%), m.p. 152—154 ℃ (Lit.26 153—154 ℃).
Aldehyde/ketone
[4-(4-bromophenyl)thiazol-2-yl]-
hydrazone (5a—5d, 8a, 8b)
+
-1
To a suspension of compounds 2a—2d, 7a or 7b (10
mmol) in absolute ethanol (25 mL) and DMF (0.5 mL),
was added the solution of 1 (2.78 g, 10 mmol) in abso-
lute ethanol (25 mL). The mixture was heated under
reflux for 3 h on a water bath. The product that sepa-
rated out on cooling was collected by filtration and
recrystallized from EtOH/DMF.
3395.45, 1603.70 cm ; MS m/z (%): 395.05 (M +4,
7.99), 393.05 (M++2, 27.71), 391.05 (M+, 20.54),
256.95 (12.28), 256.00 (100.00), 255.05 (15.31), 254.00
(97.88), 213.95 (17.99), 211.95 (18.05), 184.00 (4.91),
182.00 (5.96), 176.05 (5.20), 175.10 (14.99), 174.10
(90.16), 173.15 (8.68), 148.10 (5.29), 147.10 (12.91),
146.10 (13.71), 134.05 (5.28), 133.05 (9.28), 120.05
(7.26), 111.00 (11.39), 103.05 (9.95), 102.05 (19.78),
89.05 (19.24), 76.00 (9.78), 75.00 (24.41), 74.05 (5.85),
63.00 (6.18), 51.00 (7.87), 50.00 (9.12).
N-Benzylidene-N'-[4-(4-bromophenyl)thiazol-2-
yl]hydrazine (5a) 2.79 g (78%), m.p. 196—198 ℃;
1H NMR (DMSO-d6) δ: 7.33—7.41 (m, 4H, Ar-H, thi-
azole-H), 7.57 (d, J=8.4 Hz, 2H, Ar-H), 7.63 (d, J=6.9
Hz, 2H, Ar-H), 7.78 (d, J=8.4 Hz, 2H, Ar-H), 8.00 (s,
1H, =CH), 12.17 (s, 1H, D2O-exchangeable, NH); IR
N'-[4-(4-Bromophenyl)thiazol-2-yl]-N-(4-methyl-
2-pentylidene)hydrazine (8a) 2.82 g (80%), m.p.
180—182 ℃; 1H NMR (DMSO-d6) δ: 0.85 [d, J=6.85
Hz, 6H, (CH3)2CH], 1.86 (s, 3H, CH3), 1.89—1.93 [m,
1H, CH(CH3)2], 2.07 (d, J=6.9 Hz, 2H, CH2CH), 7.28
(s, 1H, thiazole-H), 7.56 (d, J=8.4 Hz, 2H, Ar-H), 7.75
(d, J=8.4 Hz, 2H, Ar-H), 10.73 (s, 1H, D2O-exchange-
-1
(KBr) ν: 3296.12, 156+2.23 cm ; MS m/z (%): 359
(M++2, 12.6), 357 (M , 18.2), 256 (47.0), 254 (47.5),
214 (11.2), 212 (9.5), 175 (11.6), 174 (100), 104 (16.2),
103 (28.6), 102 (14.3), 90 (10.6), 89 (27.8), 77 (75.6),
76 (15.3), 75 (18.6), 63 (19.8), 52 (12.4), 51 (63.4).
Anal. calcd for C16H12BrN3S: C 53.64, H 3.38, N 11.73;
found C 53.48, H 3.03, N 11.50.
-1
able, NH); IR (KBr) ν: 3056.96, 1602.74 cm ; MS m/z
(%): 353 (M++2, 21.7), 351 (M+, 11.6), 296 (15.7),
294 (37.9), 269 (14.6), 267 (7.6), 256 (11.1), 254 (9.6),
214 (7.1), 212 (5.6), 175 (9.6), 174 (38.4), 134 (12.6),
133 (8.6), 103 (17.2), 102 (9.1), 101 (8.1), 89 (8.1), 84
(22.7), 82 (40.9), 81 (22.7), 80 (31.3), 75 (17.2), 57
(100), 56 (11.6), 55 (13.6), 51 (18.2).
N'-[4-(4-Bromophenyl)thiazol-2-yl]-N-(4-nitroben-
zylidene)hydrazine (5b) 3.47 g (86%), m.p. 270—
1
272 ℃; H NMR (DMSO-d6) δ: 7.43 (s, 1H, thia-
zole-H), 7.56 (d, J=8.4 Hz, 2H, Ar-H), 7.77 (d, J=8.4
Hz, 2H, Ar-H), 7.84 (d, J=8.4 Hz, 2H, Ar-H), 8.06 (s,
1H, =CH), 8.22 (d, J=8.4 Hz, 2H, Ar-H), 12.58 (s,
1H, D2O-exchangeable, NH); IR (KBr) ν: 3292.26,
N'-[4-(4-Bromophenyl)thiazol-2-yl]-N-cyclopentyl-
idenehydrazine (8b) 2.66 g (79%), m.p. 214—216
℃ (Lit.14 213—215 ℃); H NMR (DMSO-d6) δ: 1.65
1
-1
+
1556.45 cm ; MS m/z (%): 404 (M +2, 13.3), 402
(M+, 14.8), 256 (42.6), 254 (39.9), 214 (11.3), 212
(13.7), 174 (100), 127 (71.2), 102 (13.0), 101 (3.9), 89
(19.4), 76 (33.1), 75 (20.7), 63 (17.3), 56 (69.8). Anal.
calcd for C16H11BrN4O2S: C 47.66, H 2.75, N 13.89;
found C 47.46, H 2.47, N 13.74.
(quintet, J=6.9 Hz, 2H, CH2CH2CH2CH2), 1.73 (quin-
tet, J=6.9 Hz, 2H, CH2CH2CH2CH2), 2.32 (t, J=6.85
Hz, 4H, CH2CH2CH2CH2), 7.28 (s, 1H, thiazole-H),
7.56 (d, J=8.4 Hz, 2H, Ar-H), 7.75 (d, J=8.4 Hz, 2H,
Ar-H), 10.70 (s, 1H, D2O-exchangeable, NH); IR (KBr)
-1
ν: 3182.33, 1627.81, 1560.30 cm ; MS m/z (%): 337
(M++2, 14.3), 335 (M+, 21.9), 308 (12.4), 306 (20.0),
256 (11.1), 254 (17.8), 214 (7.9), 212 (7.3), 175 (14.3),
174 (100), 133 (12.1), 132 (14.0), 103 (13.7), 102 (13.7),
89 (29.5), 83 (33.7), 82 (65.7), 81 (18.1), 80 (40.6), 79
(14.3), 76 (17.8), 75 (14.9), 74 (10.5), 63 (14.3), 55
(63.2), 54 (52.4), 51 (13.7).
N'-[4-(4-Bromophenyl)thiazol-2-yl]-N-(4-methoxy-
benzylidene)hydrazine (5c)
3.18 g (82%), m.p.
1
208—210 ℃; H NMR (DMSO-d6) δ: 3.74 (s, 3H,
CH3O), 6.96 (d, J=8.4 Hz, 2H, Ar-H), 7.33 (s, 1H, thi-
azole-H), 7.55, 7.57 (2d, J=8.4, 9.15 Hz, 4H, Ar-H),
7.75 (d, J=8.4 Hz, 2H, Ar-H), 7.98 (s, 1H, =CH),
11.96 (s, 1H, D2O-exchangeable, NH); IR (KBr) ν:
+
-1
Aldhyde-N"-acetyl-N"-[4-(4-bromophenyl)thiazol-2-
3227.65, 1606.59 cm ; MS m/z (%): 389.10 (M +2,
22.60), 387.10 (M+ , 22.14), 258.00 (4.83), 256.95
(12.42), 256.00 (100.00), 255.05 (15.33), 254.00 (98.28),
213.95 (16.76), 211.95 (16.76), 184.00 (4.49), 182.00
(5.72), 175.05 (9.76), 174.05 (43.06), 173.15 (5.75),
148.10 (4.85), 147.10 (7.50), 146.10 (8.68), 134.10
(21.83), 133.10 (12.41), 120.10 (9.18), 107.05 (7.08),
103.05 (7.08), 102.05 (4.96), 92.05 (17.84), 91.05 (9.14),
77.05 (24.76), 76.05 (6.90), 75.00 (5.14), 64.05 (9.81),
63.05 (8.24), 51.00 (6.75), 50.05 (4.61).
yl]hydrazone 6a, 6b
A cold solution of 5a or 5b (1.5 mmol) in dry pyri-
dine (5.0 mL) was treated with acetic anhydride (5.0 mL)
and the mixture was kept for 24 h at room temperature.
It was poured onto crushed ice and the product was fil-
tered off, washed with water, dried and recrystallized
from EtOH.
N"-Aceto-N'-benzylidene-N"-[4-(4-bromophenyl)-
thiazol-2-yl]hydrazine (6a) 0.45 g (75%), m.p. 174—
598
© 2010 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2010, 28, 594— 600